|Articles|February 17, 2021
VivaLNK Offers Wearable ECG Solution for 6MWT
Advertisement
VivaLNK has announced the availability of a wearable ECG monitoring solution designed to wirelessly capture ECG and heart rate during a six-minute walk test (6MWT).
The VivaLNK solution is used for clinical research in a variety of applications, such as cardiac rehab, digital biomarkers of arrhythmia onset, and pharmaceutical clinical trials, and includes a wearable ECG patch, a specialized mobile app, and cloud data services. In these studies, patients wear the wireless ECG patch while a clinician is able to monitor and control the test using a mobile app. Data collected during the test is then consolidated into a centralized database in the cloud for post analysis.
For more information, click here.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
- Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients
September 12th 2025
- Latest NIMBLE Study Results Highlight Progress in gMG Research
September 12th 2025
- ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
September 11th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Fast Tracks Sanofi’s Intravitreal Gene Therapy for Neovascular Age-Related Macular Degeneration
2
Phase III BRUIN CLL-313 Trial Finds Jaypirca Extends Progression-Free Survival in Treatment-Naïve CLL/SLL
3
Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients
4
Latest NIMBLE Study Results Highlight Progress in gMG Research
5